Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles

The folding of monomeric antigens and their subsequent assembly into higher ordered structures are crucial for robust and effective production of nanoparticle (NP) vaccines in a timely and reproducible manner. Despite significant advances in in silico design and structure-based assembly, most engine...

Full description

Bibliographic Details
Main Authors: Young-Seok Kim, Ahyun Son, Jihoon Kim, Soon Bin Kwon, Myung Hee Kim, Paul Kim, Jieun Kim, Young Ho Byun, Jemin Sung, Jinhee Lee, Ji Eun Yu, Chan Park, Yeon-Sook Kim, Nam-Hyuk Cho, Jun Chang, Baik L. Seong
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.01093/full
id doaj-7d5a9fc141994285863439d81f58903e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Young-Seok Kim
Young-Seok Kim
Ahyun Son
Jihoon Kim
Jihoon Kim
Soon Bin Kwon
Soon Bin Kwon
Myung Hee Kim
Paul Kim
Paul Kim
Jieun Kim
Young Ho Byun
Jemin Sung
Jemin Sung
Jinhee Lee
Jinhee Lee
Ji Eun Yu
Ji Eun Yu
Chan Park
Chan Park
Yeon-Sook Kim
Nam-Hyuk Cho
Nam-Hyuk Cho
Jun Chang
Baik L. Seong
Baik L. Seong
spellingShingle Young-Seok Kim
Young-Seok Kim
Ahyun Son
Jihoon Kim
Jihoon Kim
Soon Bin Kwon
Soon Bin Kwon
Myung Hee Kim
Paul Kim
Paul Kim
Jieun Kim
Young Ho Byun
Jemin Sung
Jemin Sung
Jinhee Lee
Jinhee Lee
Ji Eun Yu
Ji Eun Yu
Chan Park
Chan Park
Yeon-Sook Kim
Nam-Hyuk Cho
Nam-Hyuk Cho
Jun Chang
Baik L. Seong
Baik L. Seong
Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
Frontiers in Immunology
nanoparticle
virus-like particle
chaperone
ferritin
Middle East respiratory syndrome coronavirus
receptor-binding domain
author_facet Young-Seok Kim
Young-Seok Kim
Ahyun Son
Jihoon Kim
Jihoon Kim
Soon Bin Kwon
Soon Bin Kwon
Myung Hee Kim
Paul Kim
Paul Kim
Jieun Kim
Young Ho Byun
Jemin Sung
Jemin Sung
Jinhee Lee
Jinhee Lee
Ji Eun Yu
Ji Eun Yu
Chan Park
Chan Park
Yeon-Sook Kim
Nam-Hyuk Cho
Nam-Hyuk Cho
Jun Chang
Baik L. Seong
Baik L. Seong
author_sort Young-Seok Kim
title Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
title_short Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
title_full Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
title_fullStr Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
title_full_unstemmed Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
title_sort chaperna-mediated assembly of ferritin-based middle east respiratory syndrome-coronavirus nanoparticles
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-05-01
description The folding of monomeric antigens and their subsequent assembly into higher ordered structures are crucial for robust and effective production of nanoparticle (NP) vaccines in a timely and reproducible manner. Despite significant advances in in silico design and structure-based assembly, most engineered NPs are refractory to soluble expression and fail to assemble as designed, presenting major challenges in the manufacturing process. The failure is due to a lack of understanding of the kinetic pathways and enabling technical platforms to ensure successful folding of the monomer antigens into regular assemblages. Capitalizing on a novel function of RNA as a molecular chaperone (chaperna: chaperone + RNA), we provide a robust protein-folding vehicle that may be implemented to NP assembly in bacterial hosts. The receptor-binding domain (RBD) of Middle East respiratory syndrome-coronavirus (MERS-CoV) was fused with the RNA-interaction domain (RID) and bacterioferritin, and expressed in Escherichia coli in a soluble form. Site-specific proteolytic removal of the RID prompted the assemblage of monomers into NPs, which was confirmed by electron microscopy and dynamic light scattering. The mutations that affected the RNA binding to RBD significantly increased the soluble aggregation into amorphous structures, reducing the overall yield of NPs of a defined size. This underscored the RNA-antigen interactions during NP assembly. The sera after mouse immunization effectively interfered with the binding of MERS-CoV RBD to the cellular receptor hDPP4. The results suggest that RNA-binding controls the overall kinetic network of the antigen folding pathway in favor of enhanced assemblage of NPs into highly regular and immunologically relevant conformations. The concentration of the ion Fe2+, salt, and fusion linker also contributed to the assembly in vitro, and the stability of the NPs. The kinetic “pace-keeping” role of chaperna in the super molecular assembly of antigen monomers holds promise for the development and delivery of NPs and virus-like particles as recombinant vaccines and for serological detection of viral infections.
topic nanoparticle
virus-like particle
chaperone
ferritin
Middle East respiratory syndrome coronavirus
receptor-binding domain
url http://journal.frontiersin.org/article/10.3389/fimmu.2018.01093/full
work_keys_str_mv AT youngseokkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT youngseokkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT ahyunson chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jihoonkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jihoonkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT soonbinkwon chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT soonbinkwon chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT myungheekim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT paulkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT paulkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jieunkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT younghobyun chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jeminsung chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jeminsung chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jinheelee chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jinheelee chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jieunyu chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT jieunyu chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT chanpark chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT chanpark chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT yeonsookkim chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT namhyukcho chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT namhyukcho chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT junchang chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT baiklseong chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
AT baiklseong chapernamediatedassemblyofferritinbasedmiddleeastrespiratorysyndromecoronavirusnanoparticles
_version_ 1725293866342416384
spelling doaj-7d5a9fc141994285863439d81f58903e2020-11-25T00:39:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-05-01910.3389/fimmu.2018.01093346199Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus NanoparticlesYoung-Seok Kim0Young-Seok Kim1Ahyun Son2Jihoon Kim3Jihoon Kim4Soon Bin Kwon5Soon Bin Kwon6Myung Hee Kim7Paul Kim8Paul Kim9Jieun Kim10Young Ho Byun11Jemin Sung12Jemin Sung13Jinhee Lee14Jinhee Lee15Ji Eun Yu16Ji Eun Yu17Chan Park18Chan Park19Yeon-Sook Kim20Nam-Hyuk Cho21Nam-Hyuk Cho22Jun Chang23Baik L. Seong24Baik L. Seong25Department of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaGraduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaLife Science and Biotechnology, Underwood International College, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaDivision of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, South KoreaDepartment of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South KoreaGraduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South KoreaDepartment of Biotechnology, College of Life Sciences and Biotechnology, Yonsei University, Seoul, South KoreaVaccine Translational Research Center, Yonsei University, Seoul, South KoreaThe folding of monomeric antigens and their subsequent assembly into higher ordered structures are crucial for robust and effective production of nanoparticle (NP) vaccines in a timely and reproducible manner. Despite significant advances in in silico design and structure-based assembly, most engineered NPs are refractory to soluble expression and fail to assemble as designed, presenting major challenges in the manufacturing process. The failure is due to a lack of understanding of the kinetic pathways and enabling technical platforms to ensure successful folding of the monomer antigens into regular assemblages. Capitalizing on a novel function of RNA as a molecular chaperone (chaperna: chaperone + RNA), we provide a robust protein-folding vehicle that may be implemented to NP assembly in bacterial hosts. The receptor-binding domain (RBD) of Middle East respiratory syndrome-coronavirus (MERS-CoV) was fused with the RNA-interaction domain (RID) and bacterioferritin, and expressed in Escherichia coli in a soluble form. Site-specific proteolytic removal of the RID prompted the assemblage of monomers into NPs, which was confirmed by electron microscopy and dynamic light scattering. The mutations that affected the RNA binding to RBD significantly increased the soluble aggregation into amorphous structures, reducing the overall yield of NPs of a defined size. This underscored the RNA-antigen interactions during NP assembly. The sera after mouse immunization effectively interfered with the binding of MERS-CoV RBD to the cellular receptor hDPP4. The results suggest that RNA-binding controls the overall kinetic network of the antigen folding pathway in favor of enhanced assemblage of NPs into highly regular and immunologically relevant conformations. The concentration of the ion Fe2+, salt, and fusion linker also contributed to the assembly in vitro, and the stability of the NPs. The kinetic “pace-keeping” role of chaperna in the super molecular assembly of antigen monomers holds promise for the development and delivery of NPs and virus-like particles as recombinant vaccines and for serological detection of viral infections.http://journal.frontiersin.org/article/10.3389/fimmu.2018.01093/fullnanoparticlevirus-like particlechaperoneferritinMiddle East respiratory syndrome coronavirusreceptor-binding domain